792 results on '"BELLONE S."'
Search Results
102. Valutazione della sensibilità periferica all'insulina durante la fase di transizione e nei giovani adulti con deficit di GH
103. Use of PPM (Plant Preservative Mixture) to control bacterial contaminants in the multiplication in vitro of sugarcane
104. Hypopituitarism induced by traumatic brain injury (TBI) in adolescence and young adulthood
105. Utilizzo della tecnica di microarray su cellule periferiche della serie bianca per lo studio dell'espressione genica in pazienti con deficit di GH: dati preliminari
106. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium:identification of novel candidate molecular markers for cervical cancer diagnosis and therapy
107. treatment options for endometrial cancer
108. Ghrelin secretion in childhood is refractory to the inhibitory effect of feeding
109. Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo
110. Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation
111. Solitomab, an EpCAM/CD3 bispecific antibody (BiTE®), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo
112. A Circuital Model of Switching Behaviour of 4H-SiC p+-n-n+ Diodes Valid at any Current and Temperature
113. The nutritional status has no major role in the age-related reduction of IGF-I secretion
114. Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells
115. Efficient low temperature c-Si surface passivation using a-Si grown by PECVD
116. The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma. Cancer. 2003 Nov 1;98(9):1898-904
117. GHRELIN: PERIPHERAL ENDOCRINE AND NON-ENDOCRINE ACTIVITIES
118. In vitro induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes from patients with locally advanced breast cancer by tumor antigen-pulsed autologous dendritic cells
119. Growth hormone deficiency in the transition adolescent: should treatment be continued in adult life?
120. Thyroid metastases from renal clear cell carcinoma: a cyto-histological study of two cases
121. TUMOR-INFILTRATING LYMPHOCYTES CONTAIN HIGHER NUMBERS OF TYPE 1 CYTOKINE EXPRESSORS AND DR+ T CELLS COMPARED WITH LYMPHOCYTES FROM TUMOR DRAINING LYMPH NODES AND PERIPHERAL BLOOD IN PATIENTS WITH CANCER OF THE UTERINE CERVIX
122. INCREASED LEVELS OF INTERLEUKIN-10 AND TRANSFORMING GROWTH FACTOR-BETA IN THE PLASMA AND ASCITIC FLUID OF PATIENTS WITH ADVANCED OVARIAN CANCER
123. Valutazione dell’ipertireotropinemia isolata e dei fattori di rischio ad essa correlati
124. PHENOTYPIC AND FUNCTIONAL ANALYSIS OF TUMOR-INFILTRATING LYMPHOCYTES COMPARED WITH TUMOR-ASSOCIATED LYMPHOCYTES FROM ASCITIC FLUID AND PERIPHERAL BLOOD LYMPHOCYTES IN PATIENTS WITH ADVANCED OVARIAN CANCER
125. A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer
126. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test
127. INDUCTION OF OVARIAN TUMOR-SPECIFIC CD CYTOTOXIC T LYMPHOCYTES BY ACID-ELUTED PEPTIDE-PULSED AUTOLOGOUS DENDRITIC CELLS
128. Parietal cell protrusions with fundic gland cysts and fundic gland polyps: Are they distinguishable? [3] (multiple letters)
129. Evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli in Prader-Willi
130. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults
131. Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy
132. Al+ Implanted Anode for 4H-SiC p-i-n Diodes
133. Reliability of provocative tests to asess growth hormone secretory status. study in 472 normally grown children
134. Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy.
135. Measurement of height velocity is an useful marker for monitoring pituitary function in patients who had traumatic brain injury
136. A model of the voltage barrier in the channel of 4H-SiC normally-off JFET's
137. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy
138. Mammaglobin B (SCGB2A1)-specific CD8+ cytotoxic T lymphocytes (CTL) are highly effective in killing autologous chemotherapy resistant ovarian cancer cells: Implications for SCGB2A1 dendritic cell-based therapeutic vaccines
139. Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression
140. Acylated/unacylated ghrelin ratio in cord blood: correlation with anthropometric and metabolic parameters and pediatric lifespan comparison
141. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer
142. Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling.
143. The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer.
144. A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer
145. Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab
146. Related Growth Parameters in Soybean Plants Inoculated withAzospirillum brasilense
147. The effect of intraperitoneal administration of clostridium perfringens enterotoxin on chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice.
148. Uterine serous papillary carcinomas overexpress human trophoblast cell surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody
149. Analytical model of GaAs BMFET structures
150. Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.